Abingem Gemcitabine 1 g Injection
700.0 INR/Vial
Product Details:
- Origin INDIA
- Salt Composition Gemcitabine 1 g
- Indication Anticancer/Chemotherapy (Treatment of non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer)
- Dosage Form Lyophilized Powder for Injection
- Feature Other
- Ingredients Other
- Storage Instructions Store below 25 C, protect from light, do not freeze
- Click to View more
X
Abingem Gemcitabine 1 g Injection Price And Quantity
- 1 Vial
- 700.0 INR/Vial
- Prescription Drug
- Abinaya Pharmaceuticals
- Intravenous
- Meets USP standards
- 1 Vial of 1 g
- Reconstitute with sterile saline before administration
- Glass vial
- Approved by relevant drug authorities
- Adults
- Hypersensitivity to Gemcitabine
Abingem Gemcitabine 1 g Injection Product Specifications
- Gemcitabine 1 g
- INDIA
- Other
- Lyophilized Powder for Injection
- Other
- Store below 25 C, protect from light, do not freeze
- Anticancer/Chemotherapy (Treatment of non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer)
- 24 Months Months
- Prescription Drug
- Abinaya Pharmaceuticals
- Intravenous
- Meets USP standards
- 1 Vial of 1 g
- Reconstitute with sterile saline before administration
- Glass vial
- Approved by relevant drug authorities
- Adults
- Hypersensitivity to Gemcitabine
Abingem Gemcitabine 1 g Injection Trade Information
- 100 Vial Per Month
- 7 Days
Product Description
roduct introduction
Abingem 1000mg Injection is used in the treatment of non-small cell lung cancer, breast cancer, pancreatic cancer, urinary bladder cancer, and ovarian cancer.
Abingem 1000mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nausea, vomiting, loss of appetite, hair loss and low blood platelets. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.
Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Precise Formulation for Reliable Oncology Care
Abingem Gemcitabine 1 g Injection offers a dependable solution in cancer therapy, manufactured to strict quality standards and meeting USP specifications. The lyophilized powder ensures stability and purity until reconstitution. Provided in a single-use vial, it's suitable for adults and requires prescription for safe, effective administration. Its approved indications span multiple cancer types, delivering flexibility in chemotherapy regimens.
Simple Reconstitution and Safe Administration
This injection is to be administered intravenously after reconstituting the lyophilized powder with sterile saline. The preparation process ensures the medicine's activity and sterility. Healthcare professionals should handle the reconstitution and administration, adhering to standard protocols to minimize contamination and maximize patient safety.
FAQ's of Abingem Gemcitabine 1 g Injection:
Q: How should Abingem Gemcitabine 1 g Injection be prepared before use?
A: This medication must be reconstituted with sterile saline to form a solution before intravenous injection. Only qualified healthcare providers should perform the reconstitution and administration.Q: What is the recommended route and frequency of administration for this injection?
A: Abingem Gemcitabine 1 g Injection is administered intravenously. The dosage frequency and treatment cycles are determined by the treating oncologist, based on the patient's condition and cancer type.Q: When is Abingem Gemcitabine typically prescribed?
A: This medicine is indicated for adult patients diagnosed with certain cancers, including non-small cell lung, pancreatic, breast, ovarian, and bladder cancer. It is prescribed as part of chemotherapy protocols.Q: Where should the product be stored after purchase?
A: Store the vial below 25C in a place protected from light. Do not freeze the product. Ensure it remains in its original packaging until ready to reconstitute and use.Q: What are the contraindications for using Abingem Gemcitabine?
A: This injection should not be used in patients with known hypersensitivity to Gemcitabine or any of its ingredients. Consult with your doctor for a full assessment before starting treatment.Q: What benefits does Abingem Gemcitabine offer in cancer treatment?
A: Abingem Gemcitabine acts as an effective chemotherapy agent, targeting and inhibiting the growth of cancer cells in various malignancies. Its proven efficacy and regulatory approval ensure it is safe and suitable for eligible adult patients.Q: Who can supply or export Abingem Gemcitabine 1 g Injection in India?
A: Abingem Gemcitabine is available through authorized dealers, distributors, exporters, importers, manufacturers, retailers, suppliers, traders, and wholesalers across India. Abinaya Pharmaceuticals is the marketing authorization holder.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Injection' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
